Skip to main content
GoodMoatv1.3
Sign in
CLDX logo

CLDX

CompareEarnings: Aug 31, 2026

Celldex Therapeutics Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Visit www.celldex.com.

Current Price

$31.34

-3.42%
Profile
Valuation (TTM)
Market Cap$2.09B
P/E-7.35
EV—
P/B3.96
Shares Out66.57M
P/Sales2408.99
Revenue$866000.00
EV/EBITDA—

Celldex Therapeutics Inc (CLDX) Company Profile

CLDX Company Information

Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients.

Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases.

Visit www. celldex. com.

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

New Jersey, USA

CLDX Key Officers

Key officers data coming soon

CLDX Company Profile

Celldex Therapeutics Inc (CLDX) is a Healthcare company in the Biotechnology industry. It trades on NASDAQ. The company is based in New Jersey, USA.

Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Visit www.celldex.com.

Market cap is $2.09B. There are 66.6M shares outstanding.

See the full Celldex Therapeutics Inc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if CLDX is a good investment.